Portulaca oleracea Extract Ameliorates Testosterone Propionate‐Induced Benign Prostatic Hyperplasia in Male Sprague‐Dawley Rats
Veterinary Medicine and Science · 2025
DOI: 10.1002/vms3.70184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Medicine and Science, 2025. Verfasst von Young-Ju Lim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Yeungnam University College of Medicine, Yeungnam University Medical Center, Daegu, Republic of Korea. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Rats, Sprague-Dawley, Portulaca, Testosterone Propionate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Benign prostatic hyperplasia (BPH) is a distressing health problem that can cause serious complications in aging men. Androgens are implicated in the causation of BPH. Portulaca oleracea (PO) is a natural product with diverse pharmacological effects. The objective of this study was to investigate the effect of PO in a rat model of testosterone propionate (TP)‐induced BPH and explore the underlying mechanisms. Thirty‐five Sprague‐Dawley (SD) rats were divided into the following equal groups ( n = 7): normal control (NC) group, TP (3 mg/kg) group, finasteride (10 mg/kg) group, 25 and 50 mg/kg PO groups. At the end of the experiment, the body weights (BWs) of the rats were measured before they were euthanized to the establishment obtain serum and prostate weight (PW). TP‐induced levels of androgen‐related proteins in the prostate were also investigated. In the TP group, prostate size, BW, serum DHT level, prostate epithelial cell thickness and androgen‐related protein level were higher than those in the NC group ( p < 0.001). PO reversed TP‐induced BPH in a dose‐dependent manner ( p < 0.01) and its effect was similar to that of finasteride. A similar effect of PO on the androgen‐related protein level was also observed. We successfully established a TP‐induced BPH rat model. This is the first study to demonstrate that inhibition of androgen‐related proteins using PO can alleviate BPH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Yeungnam University College of Medicine, Yeungnam University Medical Center, Daegu, Republic of Korea.
- Food Science R&D Center, Kolmar BNH CO., LTD, Seoul, Republic of Korea.
- National Institute for Korean Medicine Development, Gyeongbuk, Republic of Korea.
- Preclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDI Hub), Daegu, Republic of Korea.
- Center for Nonclinical Development, HK inno.N, Icheon-si, Gyeonggi-do, Republic of Korea.
- Department of Veterinary Tissue Engineering, College of Veterinary Medicine, Kyungpook National University, Daegu, Republic of Korea.
ORCID-Profile: Min-Soo Seo
Zitieren
APA
Lim, Y. J., Kim, H. R., Lee, S. B., Kim, S. B., Kim, D. H., So, J. H., Kang, K. K., Sung, S. E., Choi, J. H., Sung, M., Lee, Y. J., Park, W. T., Lee, G. W., Kim, S. K., & Seo, M. S. (2025). Portulaca oleracea Extract Ameliorates Testosterone Propionate‐Induced Benign Prostatic Hyperplasia in Male Sprague‐Dawley Rats. Veterinary Medicine and Science. https://doi.org/10.1002/vms3.70184
Vancouver
Lim YJ, Kim HR, Lee SB, Kim SB, Kim DH, So JH, et al. Portulaca oleracea Extract Ameliorates Testosterone Propionate‐Induced Benign Prostatic Hyperplasia in Male Sprague‐Dawley Rats. Veterinary Medicine and Science. 2025. doi:10.1002/vms3.70184
BibTeX
@article{Lim2025,
author = {Lim, Young-Ju and Kim, Hye Rim and Lee, Seul Bi and Kim, Sang Back and Kim, Dong-Hee and So, Jae-Hyun and Kang, Kyung-Ku and Sung, Soo-Eun and Choi, Joo-Hee and Sung, Minkyoung and Lee, Yeon-Ji and Park, Wook-Tae and Lee, Gun Woo and Kim, Seul-Ki and Seo, Min-Soo},
title = {Portulaca oleracea Extract Ameliorates Testosterone Propionate‐Induced Benign Prostatic Hyperplasia in Male Sprague‐Dawley Rats},
journal = {Veterinary Medicine and Science},
year = {2025},
doi = {10.1002/vms3.70184}
}
EUVIMED